Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9⁺ T Cells.

ABSTRACT: Gene editing of primary T cells is a difficult task. However, it is important for research and especially for clinical T-cell transfers. CRISPR/Cas9 is the most powerful gene-editing technique. It has to be applied to cells by either retroviral transduction or electroporation of ribonucleoprotein complexes. Only the latter is possible with resting T cells. Here, we make use of Cas9 transgenic mice and demonstrate nucleofection of pre-stimulated and, importantly, of naive CD3⁺ T cells with guideRNA only. This proved to be rapid and efficient with no need of further selection. In the mixture of Cas9⁺CD3⁺ T cells, CD4⁺ and CD8⁺ conventional as well as regulatory T cells were targeted concurrently. IL-7 supported survival and naivety in vitro, but T cells were also transplantable immediately after nucleofection and elicited their function like unprocessed T cells. Accordingly, metabolic reprogramming reached normal levels within days. In a major mismatch model of GvHD, not only ablation of NFATc1 and/or NFATc2, but also of the NFAT-target gene IRF4 in naïve primary murine Cas9⁺CD3⁺ T cells by gRNA-only nucleofection ameliorated GvHD. However, pre-activated murine T cells could not achieve long-term protection from GvHD upon single NFATc1 or NFATc2 knockout. This emphasizes the necessity of gene-editing and transferring unstimulated human T cells during allogenic hematopoietic stem cell transplantation.

SUBMITTER: Majumder S 

PROVIDER: S-EPMC8335400 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature